Author Archive: BIOtechNOW Editor

Managing Biotech Technological Innovation in a New Era

Written by Kelly Cappio, BIO. This session focused on technological innovations and how they can be used to prevent, identify, or respond to new natural or man-made threats. As stated by Dr. Alan Rudolph, “We face a very dynamic threat space.” Dr. Rudolph, Director of the Chemical and Biological Technologies Directorate at the Defense Threat Reduction Agency, discussed the strategic thrust of the agency and its recent focus on new diagnostic technologies, such as MIMIC, Read More >

Health  |  Leave a comment  |  Email This Post
Tags: ,

Current Challenges in Payment Reform

By Alyson Pusey, BIO. The Affordable Care Act created several demonstration projects to test innovative care delivery systems that increase quality of care while decreasing costs.  Speaking as a panelist was Jonathan Blum, Deputy Administrator and Director of the Center for Medicare at CMS, who discussed how the agency is thinking about payment reform.  Evidenced by the recent proposed rule on accountable care organizations (ACOs), the agency is looking to providers and the health care Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

Biotechnology Innovation: Impact of Health Reform and Deficit Control

By Alyson Pusey, BIO. With many governors around the country facing budget shortfalls, “the action is all in the states” in terms of health care cuts and cost-savings solutions, according to panelists participating. The current fiscal environment has forced cash-strapped states to look at their Medicaid programs for ways to rein in costs, and according to panelists, state lawmakers will continue to do so for the foreseeable future.  For example, as a result of the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Blogging from #BIO2011

by Stephen Albainy-Jenei, from Patent Baristas You can keep up with what’s happening at BIO 2011 on BIOTechNOW (@BIOTechNOW) plus all the BIO Official Bloggers hitting the floor at the convention. I’ll be in attendance as well as participating in the BIO Official Blogger network throughout the week.   If you’d like to meet up during the conference, drop me a note and we’ll schedule some time to have coffee together.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , ,

Beware the Liability Gaps in Biotechnology M&As

Mike Yeager, Senior Underwriting Specialist, Chubb Mergers and acquisitions continue to be a source of growth for the biotechnology industry. Even the financial crisis has not significantly slowed this trend. In fact, a weakened global economy may have further fueled consolidation as biotechnology companies sought additional efficiencies in R&D, procurement or administration. Since many biotechnology companies have complex corporate structures—some with hundreds of subsidiaries—executives at acquiring companies recognize that along with the benefits of the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,